CLS vs EXAS · P/E 44, rev $8.75B vs rev $2.76B
Celestica Inc. (CLS) versus EXACT Sciences Corporation (EXAS) — a side-by-side from cached financials, not a winner call.
Celestica Inc. (CLS) is a electronic components company listed on US.
EXACT Sciences Corporation (EXAS) is a diagnostics & research company listed on NASDAQ.
Latest reported CLS revenue for 2026-06-30 was $8.75B. Net income was $581.1M. CLS currently screens at market cap $17.99B and trailing P/E 43.6.
Latest reported EXAS revenue for 2024-12-31 was $2.76B. Net income was -$1.03B. Revenue was up 10.4% from 2023-12-31 to 2024-12-31. EXAS currently screens at market cap $20.03B.
CLS currently screens at market cap $17.99B and trailing P/E 43.6. EXAS currently screens at market cap $20.03B.
Not investment advice. Open the CLS and EXAS stock pages for the full models.
Not investment advice.